Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating radiofrequency ablation for unresectable primary or metastatic liver cancer was terminated; results have b…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma [NA]
A clinical trial evaluating stereotactic radiation therapy in combination with sorafenib for hepatocellular carcinoma was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer [Phase 2]
A Phase 2 study evaluating Avastin (bevacizumab) in combination with Xeloda (capecitabine) for advanced or metastatic hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 study evaluating sunitinib with transarterial chemoembolization for unresectable liver cancer; the trial was terminated and results …
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
This trial reported results on using Primovist/Eovist contrast-enhanced MRI to evaluate suspected or focal liver lesions in pediatric patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 study evaluating NGR-hTNF as a single agent in patients with advanced or metastatic hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC [Phase 2]
Phase 2 trial update evaluating arsenic trioxide delivered via transarterial chemoembolization for hepatocellular carcinoma, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis [NA]
A clinical trial evaluating TheraSpheres for unresectable hepatocellular carcinoma and portal vein thrombosis has completed.
-
CLINICAL_TRIALS research · 2014-05-28Clinical Trial Update: Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
This document provides an update on a clinical trial investigating the diversity of hepatitis B virus intra-host populations and host-specif…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Prospective Liver Study
A prospective liver cancer trial sponsored by Emory University has completed. The summary does not include trial results in the provided sni…
-
CLINICAL_TRIALS withdrawal · 2014-05-19Clinical Trial Update: Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
A prospective observational study of biomarkers in liver cancer (hepatocellular carcinoma) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-16Clinical Trial Update: Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study [Phase 2]
A Phase 2 pilot trial investigating increased GABAergic activity for hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: INSIGHT - Post Marketing Surveillance
INSIGHT post-marketing surveillance study completed, sponsor Bayer.
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: BMS-247550 in Treating Patients With Liver or Gallbladder Cancer [Phase 2]
A Phase 2 study of BMS-247550 in adult cholangiocarcinoma, hepatocellular carcinoma, and gallbladder cancer was terminated.
-
CLINICAL_TRIALS research · 2014-05-14Clinical Trial Update: Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
A completed genome-wide association study aiming to identify genetic predictors of response to targeted therapy in hepatocellular carcinoma …
-
CLINICAL_TRIALS research · 2014-05-06Clinical Trial Update: Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection [NA]
The document provides an update on the surgical technique and preliminary efficacy evaluation for total laparoscopic left liver resection in…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: PLA for HCC and Esophageal ca Serum
Clinical trial update from National Taiwan University Hospital regarding PLA for hepatocellular carcinoma and esophageal cancer serum; the c…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI [Phase 2]
Phase 2 trial evaluating octanoate breath test for detecting hepatocellular carcinoma compared with MRI; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial [Phase 2]
Phase II clinical trial of lenalidomide for advanced hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial [Phase 2]
A randomized Phase II trial compares sorafenib plus doxorubicin versus sorafenib alone in advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma [Phase 2]
Update reporting results from a Phase 2 trial of cetuximab in patients with unresectable or metastatic hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: SU011248 in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial of SU011248 in advanced hepatocellular carcinoma has completed. The snippet does not provide results.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of gemcitabine, oxaliplatin, and bevacizumab in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating safety and efficacy of doxorubicin-eluting microspheres delivered by transarterial embolizat…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma [Phase 2]
A Phase 2 study of sunitinib in patients with advanced or inoperable fibrolamellar hepatocellular carcinoma has been terminated.